Malignant Minor Salivary gland neoplasms ofLarynx: Our Experience-Reference-Cited by-同舟云学术

Malignant Minor Salivary gland neoplasms ofLarynx: Our Experience

Published:2023-09-29 Issue:5 Volume:77 Page:1-7
ISSN:0030-6657
Container-title:Otolaryngologia Polska
language:
Short-container-title:Otolaryngol Pol

Author:

Joshi Poonam¹,Bhattacharya Kajari²^ORCID,Menon Munita Bal³^ORCID,Ghosh Laskar Sarbani⁴^ORCID,Joshi Amit⁵,Patil Vijay⁶^ORCID,Chaturvedi Pankaj⁷^ORCID

Affiliation:

1. Department of Head and Neck Surgery, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India

2. Department of Radiology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India

3. Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India

4. Department of Radiotherapy, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India

5. Department of Medical Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India

6. Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India

7. Department of Head and Neck Surgery, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India

Abstract

Introduction: Malignant minor salivary gland tumors are rare, accounting for fewer than 1% of all laryngeal cancers. Aim: This study aims to share our experiences regarding clinical, radiological, pathological profiles and their management. Materials and methods: The current study reviews 11 cases of malignant minor salivary gland tumors of the larynx treated surgically at our Institute between 2005 and 2019. Results: The mean age of the patients was 54 years (range 38–75 years) with six females and five males in the series (1.2:1). Subglottis and trachea were the sites of origin in 54% of the cases, and hoarseness with dyspnea were the most common presenting symptoms. There were nine Adenoid cystic and two Mucoepidermoid carcinoma patients. Surgery was the primary mode of treatment. Conclusions: Most of the larynx’s malignant minor salivary gland tumors are submucosal in origin. The outcome and prognosis vary considerably based on the tumor’s histology, grade, and stage.

Publisher

Index Copernicus

Subject

Otorhinolaryngology

Link

https://otolaryngologypl.com/gicid/pdf/01.3001.0053.4040

Reference58 articles.

1. Spiro R.H., Spiro J.D.: Cancer of the salivary glands. W: Cancer of the Head and Neck,red. E.N. Myers, J.Y. Suen. Churchill Livingstone, New York, NY 1989, 645–668.

2. Pires F.R., Pringle G.A., Almeida O.P., Chen S.Y.: Intra-oral minor salivary glandtumors: a clinicopathological study of 546 cases. Oral Oncol., 2007; 43: 463–470.

3. Oliveira F.A., Duarte E.C., Taveira C.T. et al.: Salivary gland tumor: a reviewof 599 cases in a Brazilian population. Head Neck Pathol., 2009; 3: 271–275.

4. Batsakis J.G., Luna M.A., el-Naggar A.K.: Nonsquamous carcinomas of thelarynx. Ann Otol Rhinol Laryngol., 1992; 101: 1024–1026.

5. Zero E., Golubović M.: Laryngeal adenoid cystic carcinoma. Acta OtorhinolaryngolItal., 2009; 29: 279–282.